Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Configuration of the TP53 gene as an independent prognostic parameter of myelodysplastic syndrome.

Leukemia & lymphoma - 1 Jun 2003

Horiike Shigeo, Kita-Sasai Yuri, Nakao Mitsushige, Taniwaki Masafumi

Abstract excerpt

Myelodysplastic syndrome (MDS) consists of a heterogeneous group of acquired hematopoietic stem cell disorders, characterized by bone marrow failure and leukemic transformation. Since hematological manifestations and clinical outcomes vary widely among MDS patients, a considerable number of studies have tried to identify the prognostic parameters for the stratification of patients into different risk groups....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, p53
Share to Mutation
Share to Myelodysplastic Syndromes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Survival Rate

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 12854888
DOI: 10.1080/1042819031000067620

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Configuration of the TP53 gene as an independent prognostic parameter of myelodysplastic syndrome.PMID 12854888Read ↗

International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome.Semantic proximity Read ↗

[Molecular international prognostic scoring system for myelodysplastic syndromes].Semantic proximity Read ↗

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.Semantic proximity Read ↗

Prognostic models in myelodysplastic syndromes.Semantic proximity Read ↗

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutationsSemantic proximity Read ↗

Does mutational burden add to other prognostic factors in MDS?Semantic proximity Read ↗

Implications of <i>TP53</i> Allelic State for Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic SyndromesSemantic proximity Read ↗

Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System.Semantic proximity Read ↗

Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.Semantic proximity Read ↗

Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports.Semantic proximity Read ↗

Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes.Semantic proximity Read ↗

Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.